• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Disseminated Intravascular Coagulation (DIC) (1813)
Event Type  Injury  
Event Description
Dic [disseminated intravascular coagulation] utilized 2 jadas on a patient with approx.4200cc qbl where jada did not work either time/not able to control bleeding [device ineffective] case narrative: this initial spontaneous report originating from the united states, was received from a clinical educator on behalf of physician via dpoc, referring to a female patient of an unknown age.The patient's medical history, concurrent conditions, past drugs, allergies, and concomitant medications were not reported.This report concerns 1 patient and 2 devices.The physician stated that he utilized 2 vacuum-induced hemorrhage control system (jada system) (route, lot#, serial # and expiration date were not reported) for an unknown indication (product used for unknown indication) on a patient with approximately 4200 cubic centimeters (cc) quantitative blood loss (qbl) (also reported as milliliter (ml)) where vacuum-induced hemorrhage control system (jada system) did not work either time (device ineffective).In addition, it was mentioned that the patient had gone into dic (disseminated intravascular coagulation).It was reported that they were not able to control the patient¿s bleeding, hence proceeded to hysterectomy.The availability of vacuum-induced hemorrhage control system (jada system) was unknown.Patient sought medical attention.Upon internal review, the event of device ineffective were determined to be serious as it required intervention.Upon internal review, the event of disseminated intravascular coagulation was determined to be medically significant.Medical device reporting criteria: serious injury.(b)(4).
 
Manufacturer Narrative
Based on the information we have received, there is no indication that the device malfunctioned.The device is assembled according to specifications.In process and finished product testing are performed and approved prior to release.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JADA SYSTEM
Type of Device
INTRAUTERINE VACUUM CONTRACTION SYSTEM
Manufacturer (Section D)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer (Section G)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer Contact
30 hudson street
jersey city, NJ 07302
MDR Report Key16077488
MDR Text Key306423386
Report Number3002806821-2022-00035
Device Sequence Number1
Product Code OQY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
510K K201199
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/30/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/30/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient SexFemale
-
-